SML3857
Etamicastat
≥98% (HPLC)
别名:
(R)-5-(2-Aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydroimidazole-2-thione, (R)-5-(2-Aminoethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione, 5-(2-Aminoethyl)-1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-2H-iImidazole-2-thione, BIA 5-453
相关类别
生化/生理作用
Orally active, potent, reversible and peripherally selective dopamine-β-hydroxylase (DBH) inhibitor.
Etamicastat (BIA 5-453) is an orally active, potent, reversible and peripherally selective dopamine-β-hydroxylase (DBH) inhibitor that reduces both systolic (SBP) and diastolic (DBP) blood pressure.
Etamicastat (BIA 5-453) is an orally active, potent, reversible and peripherally selective dopamine-β-hydroxylase (DBH) inhibitor that reduces both systolic (SBP) and diastolic (DBP) blood pressure.
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Dopamine ? hydroxylase as a potential drug target to combat hypertension
Expert Opinion on Investigational Drugs, 29(9), 1043-1057 (2020)
Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453)
Drugs in R&D, 11(2), 127-136 (2011)
Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-?-hydroxylase: comparison with nepicastat
European Journal of Pharmacology, 751, 50-58 (2015)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持